Inventor · disambiguated record
Shawn Schiller
Also filed as: SCHILLER SHAWN · SCHILLER SHAWN E R · SELETSKY BORIS M
48 granted patents·23 pending applications·344 citations·filing 2003–2024
98Inventor score
Files withFORMA THERAPEUTICS INC30EISAI R&D MAN CO LTD14FOGHORN THERAPEUTICS INC11EISAI CO LTD5KOWALCZYK JAMES J2
Top patents by PatentIndex Score
71 records- 0197US10336722B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2019·22 cites·47 claims
- 0297US9428495B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted Aug 30, 2016·35 cites·32 claims
- 0397US9422281B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Aug 23, 2016·25 cites·35 claims
- 0496US11111229B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·4 cites·22 claims
- 0596US10377769B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·10 cites·28 claims
- 0696US9388161B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·34 cites·44 claims
- 0795US11497752B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2019·Granted Nov 15, 2022·7 cites·6 claims
- 0894US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 0994US10611750B2Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·7 cites·38 claims
- 1094US10472342B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Nov 12, 2019·4 cites·25 claims
- 1194US7585976B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2006·Granted Sep 8, 2009·13 cites·10 claims
- 1293US9126999B2Tetrahydropyrazolopyrimidine compoundsBOIVIN ROCH·Filed 2013·Granted Sep 8, 2015·33 cites·28 claims
- 1393US7528152B2Hemiasterlin derivatives and uses thereof in the treatment of cancerEISAI CO LTD·Filed 2007·Granted May 5, 2009·19 cites·26 claims
- 1493US7064211B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2003·Granted Jun 20, 2006·28 cites·18 claims
- 1592US12383560B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2022·Granted Aug 12, 2025·1 cites·10 claims
- 1691US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 1790US10457655B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2017·Granted Oct 29, 2019·3 cites·46 claims
- 1890US10399951B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 3, 2019·5 cites·27 claims
- 1990US9446046B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2015·Granted Sep 20, 2016·8 cites·6 claims
- 2090US8129407B2Hemiasterlin derivatives and uses thereof in the treatment of cancerKOWALCZYK JAMES J·Filed 2009·Granted Mar 6, 2012·15 cites·22 claims
- 2189US8633224B2Hemiasterlin derivatives and uses thereof in the treatment of cancerKOWALCZYK JAMES J·Filed 2012·Granted Jan 21, 2014·12 cites·20 claims
- 2287US10703764B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 2387US10450286B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 22, 2019·3 cites·27 claims
- 2486US12139487B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2023·Granted Nov 12, 2024·1 cites·102 claims
- 2586US10995078B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2020·Granted May 4, 2021·1 cites·2 claims
- 2686US7192972B2Hemiasterlin derivatives and uses thereofEISAI CO LTD·Filed 2003·Granted Mar 20, 2007·18 cites·21 claims
- 2785US7666875B2Hydantoin compoundsEISAI R&D MAN CO LTD·Filed 2006·Granted Feb 23, 2010·11 cites·30 claims
- 2883US10889592B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2017·Granted Jan 12, 2021·2 cites·28 claims
- 2983US10640500B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2017·Granted May 5, 2020·1 cites·5 claims
- 3083US9850242B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2016·Granted Dec 26, 2017·3 cites·12 claims
- 3180US12441726B2Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2021·Granted Oct 14, 2025·1 cites·40 claims
- 3280US10913753B2Thienopyridine carboxamides as ubiquitin-specific protease inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·2 cites·20 claims
- 3379US10800750B2Compounds and compositions for inhibition of FASNFORMA THERAPEUTICS INC·Filed 2019·Granted Oct 13, 2020·0 cites·20 claims
- 3479US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3578US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 3677US2025188079A1Inhibiting cyclic amp-responsive element-binding protein (creb)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3776US2023061891A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3876US2021214323A1Novel compounds and compositions for inhibition of fasnFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3974US12378242B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·19 claims
- 4074US11084831B1Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·0 cites·14 claims
- 4173US11787803B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·20 claims
- 4272US7985746B2Imidazoazepinone compoundsEISAI R&D MAN CO LTD·Filed 2007·Granted Jul 26, 2011·1 cites·10 claims
- 4371US2025066354A1Compounds and uses thereofFOGHORN THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4470US11130758B2Tetrahydropyrazolopyrimidine compoundsEISAI R&D MAN CO LTD·Filed 2020·Granted Sep 28, 2021·0 cites·9 claims
- 4567US9663486B2Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2014·Granted May 30, 2017·1 cites·14 claims
- 4665US2016257699A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 4764US11267805B2Solid forms of (4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl) piperazine-1-yl)(1-hydroxycyclopropyl)methanoneFORMA THERAPEUTICS INC·Filed 2020·Granted Mar 8, 2022·0 cites·21 claims
- 4864US2018354939A1Selectively substituted quinoline compoundsEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 4962US12351577B2Inhibiting cyclic AMP-responsive element-binding protein (CREB)FORMA THERAPEUTICS INC·Filed 2020·Granted Jul 8, 2025·0 cites·19 claims
- 5062US11325917B2Thienopyrazine carboxamides as ubiquitin-specific protease inhibitorsVALO HEALTH INC·Filed 2020·Granted May 10, 2022·0 cites·20 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →